Atrasentan Spermatogenesis and Testicular Function

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 6, 2015

Primary Completion Date

April 18, 2018

Study Completion Date

July 16, 2018

Conditions
NephropathyDiabetes
Interventions
DRUG

Atrasentan

Atrasentan

Trial Locations (13)

10117

Charite Research Organisation GmbH /ID# 154264, Berlin

10154

SCDU Nefrologia e dialisi-CMID /ID# 151673, Torino

12208

Albany Medical College /ID# 131068, Albany

14004

Hospital Universitario Reina S /ID# 151692, Córdoba

20153

Ospedale S. Carlo Borromeo /ID# 151672, Milan

60805

Research by Design, LLC /ID# 160784, Evergreen Park

62702

Southern IL Univ School of Med /ID# 129010, Springfield

70006

Crescent City Clinical Res Ctr /ID# 150989, Metairie

70112

Tulane Univ /ID# 130308, New Orleans

90404

Frank Clark Urology Center /ID# 147794, Santa Monica

92653-3621

Alliance Research Centers /ID# 125945, Laguna Hills

19004-1017

Urologic Consultants of Southeastern Pennsylvania /ID# 124277, Bala-Cynwyd

23507-1627

Eastern Virginia Med School /ID# 153740, Norfolk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY